Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,065,030
+$99,733 QoQ
Shares Held
8,131
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.99%
of 13F equity value
Holder Rank
#2,319
of 4,664 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CPA Asset Management Group, LLC holds $3,417,786 across 4 Drug Manufacturers - General names. JNJ ranks #1 (60.4% of the industry book) .
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,065,030 | 8,131 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,965,297 | 8,040 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,745,416 | 8,434 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,698,818 | 9,162 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,410,493 | 9,234 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $1,530,869 | 9,231 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,334,553 | 9,228 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,797,731 | 11,093 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,620,914 | 11,090 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $1,753,852 | 11,087 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,737,306 | 11,084 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,725,865 | 11,081 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,833,630 | 11,078 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,716,780 | 11,076 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,956,045 | 11,073 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||